Alaunos Therapeutics, Inc.

TCRT

—

Advanced chart & tools →

Alaunos Therapeutics, Inc.TCRT

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.20

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$5,000

Net income

$-4.18M

Net margin

-83520.0%

Gross margin

—

Dividends & financials

Alaunos Therapeutics, Inc. (TCRT) reported revenue of $5,000 and net income of $-4.18M, or $-2.20 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.